Skip to main content
Cytogen, Inc. logo

Cytogen, Inc. — Investor Relations & Filings

Ticker · 217330 ISIN · KR7217330000 KO Manufacturing
Filings indexed 437 across all filing types
Latest filing 2021-12-21 Major Shareholding Noti…
Country KR South Korea
Listing KO 217330

About Cytogen, Inc.

https://www.cytogenlab.com/

Cytogen, Inc. is a biotechnology company specializing in liquid biopsy platforms for precision oncology. The company has developed proprietary technology for the rapid isolation and analysis of viable Circulating Tumor Cells (CTCs) from whole blood. Its core offering, the SmartBiopsy Platform, utilizes a high-density microporous chip with microfluidics and nanotechnology to capture CTCs efficiently. This non-invasive diagnostic approach is designed to support early cancer detection, treatment monitoring, and the advancement of personalized medicine for cancer patients.

Recent filings

Filing Released Lang Actions
기타시장안내(최대주주의의무보유관련)
Major Shareholding Notification Classification · 100% confidence The document is a short announcement (366 characters) from the Korea Exchange regarding Cytogen's compliance with mandatory shareholding requirements for its largest shareholder. It does not contain full financial statements or legal proceedings, but rather serves as a regulatory notification regarding market rules and compliance status. As it is a general regulatory announcement that does not fit into specific categories like M&A or dividends, it falls under the RNS (Regulatory Filings) category.
2021-12-21 Korean
최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is an official regulatory filing from the Korean Exchange (KRX) system regarding a change in the company's largest shareholder (maximum shareholder). It details the change in ownership, the identity of the new shareholder (Ascent Bio Fund), the reason for the change (market purchase), and provides detailed information about the new shareholder entity. This type of disclosure is a standard regulatory filing for material corporate events.
2021-12-20 Korean
기타시장안내(최대주주의의무보유관련)
Major Shareholding Notification Classification · 100% confidence The document is a short regulatory notice from the Korea Exchange regarding Cytogen's change in major shareholder and the subsequent mandatory share holding requirements under KOSDAQ listing regulations. It is a regulatory announcement regarding compliance and market status rather than a financial report, proxy, or specific corporate action like a dividend or share buyback. Given its nature as a regulatory notification, it falls under the RNS category.
2021-12-20 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and Korea Exchange. This is a standard regulatory filing in South Korea (often referred to as a 5% rule filing) used to disclose significant changes in share ownership. Based on the provided categories, this fits the 'Major Shareholding Notification' (MRQ) classification, as it details the acquisition of shares by 'Ascent Bio Fund' in 'Cytogen'.
2021-12-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This type of filing is specifically used to report changes in share ownership by major shareholders or insiders. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification' (MRQ) as it details the acquisition of shares by a major shareholder (Ascent Bio Fund) in Cytogen.
2021-12-20 Korean
조회공시요구(풍문또는보도)(최대주주 변경설)
Regulatory Filings Classification · 100% confidence The document is a formal request from a regulatory body (exchange) to the company (Cytogen) regarding market rumors about a change in the largest shareholder. This is a standard regulatory inquiry/announcement that does not fit into specific categories like M&A or shareholding notifications, making it a general regulatory filing.
2021-12-17 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.